RESEARCH ON BETA CELL FUNCTION, INSULIN SENSITIVITY AMONG PRE-DIABETES POPULATION IN HANOI, VIETNAM
Main Article Content
Abstract
Studying beta cell function, insulin sensitivity, and insulin resistance by HOMA2 software. In Vietnam, published data using HOMA2 software to study beta cell function, insulin sensitivity, and insulin resistance in pre-diabetes are limited. To serve as a basis for broader studies in overweight, obese, diabetic, and hypertensive, we studied 513 subjects (85 normal people and 428 people with pre-diabetes) aged, from 18 to 69, showed that: in people with pre-diabetes, β-cell function, insulin sensitivity, insulin resistance are: 79.1±29.9 and 128.6±55.8, respectively; insulin sensitivity decreased by 19.7% compared to the control group (128.6±55.8 vs. 160.1±53.85, p<0.001), however the beta cell function between the two groups did not differ. statistical significance (79.1±29.9 versus 79.5±23.9); The index of insulin resistance in the pre-diabetes group was higher than that in the control group (0.98±0.56 versus 0.72±0.32, p<0.001).
Article Details
Keywords
insulin sensitivity, diabetes, beta cell function
References
2. Lưu Cảnh Toàn, Hoàng Trung Vinh (2006), Nghiên cứu tình trạng kháng insulin và chức năng tế bào β ở bệnh nhân ĐTĐ type 2 có tăng huyết áp, luận văn thạc sỹ y học - Học viện Quân y.
3. Abu Kholdun Al-Mahmood, Aziz Al-Safi Ismail, Faridah Abdul Rashid, Wan Mohamad Wan Bebakar (2006), Insulin sensitivity and secretory status of a healthy Malay population, Malaysian Journal of Medical Sciences, Vol.13, (suppl.2), p. 37-44.
4. Hermans MP, Levy JC, Morris RJ, Turner RC (1999), Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes, Diabetologia (1999); 42: 678–87.
5. Matthews DR (2001), Insulin resistance and beta-cell function – a clinical perspective, Diabetes, Obesity and Metabolism; 3 (Suppl. 1): S28-S33.
6. UK Prospective Diabetes Study Group (2004), Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS.67), Diabetic Medicine, Vol.22, p.306-311.
7. Wallace TM, Levy JC, Matthews DR (2004), Use and Abuse of HOMA modeling, Diabetes Care (2004); 27(6): 1487-95.
8. Alberti K.G., Zimmet P., Shaw J. (2005), The metabolic syndrome--a new worldwide definition, Diabetic Medicine, (23), pp.469-80.
9. Basu A., Pedersen M.G., Cobelli C. (2012), Prediabetes: Evaluation of Beta Cell Function, Diabetes Journal, 61(2), pp.270-71.
10. Chiasson J.L., Rabasa-Lhoret R. (2004), Prevention of Type 2 Diabetes Insulin Resistance and beta -Cell Function, Diabetes, 53(S3), pp.34-38.